Thursday, July 21, 2016

BRIEF-Puma Biotechnology announces 5-year data on breast cancer

…
extended adjuvant her2-positive early stage breast cancer
(extenet trial)
Source text for …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)